UCB S.A. - Pharma Sector clinical trials
A division of UCB S.A.
The registry lists 4 studies whose lead sponsor is UCB S.A. - Pharma Sector. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 29, 2024.
Registry sponsor names on this page
- UCB S.A. - Pharma Sector4 studies
Something wrong with this grouping? Tell us on the UCB S.A. page.
Studies
Recruiting first, then most recently updated. Showing 4 of 4. All UCB S.A. studies →
- Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset SeizuresCompletedNCT00152451Phase 2
Sponsor listed in the registry: UCB S.A. - Pharma Sector
- ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)CompletedNCT00160680Phase 4
Sponsor listed in the registry: UCB S.A. - Pharma Sector
- Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive SubjectsCompletedNCT00295022Phase 4
Sponsor listed in the registry: UCB S.A. - Pharma Sector
- A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery StrokeTerminatedNCT01883011Phase 4
Sponsor listed in the registry: UCB S.A. - Pharma Sector